C. Piazza

C. Piazza

Amministratore Delegato presso
IGL Pharma, Inc.
79 anni
Health Technology
Consumer Services
Commercial Services

Profilo

C.
Richard Piazza
was the founder of QSAM Biosciences, Inc. (founded in 2004) where he served as the Executive Chairman from 2020 to 2024.
He is currently the President & Chief Executive Officer of IGL Pharma, Inc. (since 2017) and the Chairman of NovaScan, Inc. (since 2018).
In the past, he held positions as the President & Chief Executive Officer of Maxia Pharmaceuticals, Inc. (2001-2002), VitaGen, Inc. (2002-2003), and TheraFuse, Inc. (2003-2004).
He also served as the Chief Executive Officer of SynVivo, Inc. (2014-2016) and as the Managing Director of Healthios Capital Markets LLC (2004-2007) and the Managing Partner of La Jolla Capital Partners, Inc. (2004-2007).
Additionally, he has held the title of Chairman at Chemokine Therapeutics Corp.
Dr. Piazza obtained a doctorate degree from the University of Leeds, a graduate degree from the State University of New York at Buffalo, and an undergraduate degree from The State University of New York.

Posizioni attive di C. Piazza

SocietàPosizioneInizio
Amministratore Delegato 01/01/2017
Presidente 01/11/2018

Precedenti posizioni note di C. Piazza

SocietàPosizioneFine
Fondatore 02/05/2024
Amministratore Delegato 01/01/2016
La Jolla Capital Partners, Inc.
Corporate Officer/Principal 01/01/2007
Corporate Officer/Principal 01/01/2007
Presidente 01/09/2004
Vedi nel dettaglio l'esperienza di C. Piazza

Formazione di C. Piazza

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

25

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Finance

La Jolla Capital Partners, Inc.

Health Technology

Process Industries

Health Services

Health Technology

Technology Services